Press Releases 2020-09-30T17:17:28+08:00

Press Releases

Amaran Biotech and OBI Pharma share exchange plan to form a strong synergistic cooperation

The Board of Directors of Amaran Biotechnology, Inc. passed a resolution on September 28th to exchange 67 percent of the Company’s shares with OBI Pharma, Inc. The share exchange transaction will be 53,466,000 shares of Amaran Biotech’s common stock in exchange for 10,693,200 shares of OBI Pharma’s common stock. OBI Pharma intends to issue new shares and increase capital in this transaction.

Read More »

Amaran Biotechnology Selects Stellar KLH for Cancer Vaccines

Amaran Biotechnology, Inc., a biopharmaceuticals manufacturer and leading manufacturer of a key protein utilized in immunotherapy development pipelines Stellar Biotechnologies, Inc. (Nasdaq: SBOT), have entered into an exclusive multi-year supply agreement in connection with clinical development studies of immunotherapies for metastatic breast cancer and other cancers.

Read More »